News

Fierce Pharma7h
Facing added pressure from Eli Lilly, Novo Nordisk submits for FDA approval of oral GLP-1 obesity drug
Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...
Eli Lilly says GLP-1 pill for diabetes and weight loss effective in study, plans to seek FDA approval
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
Major drug company reveals crucial weight loss pill breakthrough
It's little secret that America has a weight problem. For decades, Americans have embraced and abandoned countless ...
New York Post4d
Everything to know about the new weight loss pill that works as well as Ozempic — and when you can get it
Representatives from Lilly said the company plans to seek FDA approval to market the drug for weight loss this year and diabetes in 2026. The FDA’s review could take months, yet analysts ...
Eli Lilly Stock Soars on Oral Weight-Loss Drug Trial Results
Shares of Eli Lilly jumped 16% Thursday morning after the pharmaceutical company released clinical trial results for its oral ...
Gulf News9d
FDA-approved drug offers long-term weight loss in adults without diabetes
New Delhi: Taking tirzepatide drug once a week may produce clinically meaningful and sustained weight loss ... was approved in November 2023 by the US Food and Drug Administration (FDA) ...
Time5d
How a New Weight-Loss Pill Could Transform Health
But this one, for Lilly’s first diabetes and weight-loss pill based ... or blockbuster drug at a time. Lilly has two (and counting). In July 2024, it received FDA approval for Kisunla, an ...
Experimental Eli Lilly weight loss drug proves promising for type 2 diabetics
People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...